Search - tctmd.com

Displaying 821 - 840 of 1143

Sort: Relevancy | Date

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Piera Capranzano

October 11, 2015

Presentation TCT 2015

Surgical LAA Closure: Patient Selection and Supporting Data

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Michael Argenziano

October 11, 2015

Presentation TCT 2015

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Uwe Zeymer

October 11, 2015

Presentation TCT 2015

What Are the Management Options for the Patient With AF and DES?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Pascal Vranckx

October 11, 2015

Presentation TCT 2015

Which NOAC for Which Patient?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Christopher B. Granger

October 11, 2015

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

Presentation TCT 2015

Fundamental Knowledge: Left Atrium and Left Atrial Appendage Anatomy, Function, and Relational Pathology

Presenter: Jeff Davis, Asma Hussaini

October 10, 2015

Presentation

LAA Closure: First in Man With the Fourth-Generation Watchman Device

Presenter: J. Ledwoch

September 15, 2015

Presentation CICT 2015

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Presenter: Horst Sievert

August 01, 2015

Presentation CICT 2015

Patient Selection for the Watchman Device: The European Perspective

Presenter: Horst Sievert

August 01, 2015

Presentation CICT 2015

Watchman Patient Selection: US Perspective

Presenter: Ted Feldman

July 31, 2015

Presentation

Interventional Options for Left Atrial Appendage Exclusion

Presenter: Jonathan C. Hsu

July 11, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation TVT 2015

Case Presentation: LAA Occlusion and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Brij Maini

June 04, 2015

Presentation

Safety of LAA Exclusion With the Lariat Device

Presenter: S. Chatterjee

May 04, 2015

Presentation ECHO 2015

Case Presentation 73 Year Old Man with Bacteremia and Left Atrial Mass

Presenter: Fletcher A. Miller

April 27, 2015

Presentation CADECI 2015

SESIÓN V: Cierre de la orejuela izquierda en fibrilación auricular

Presenter: Dr. Homero A. Ram?rez Reyes

February 18, 2015

Presentation CADECI 2015

CIERRE DE LA OREJUELA DE AURICULA IZQUIERDA VS ANTICOAGULACION ORAL

Presenter: Dr. Joel Estrada Gallegos

February 18, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Advertisement

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Surgical LAA Closure: Patient Selection and Supporting Data

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

What Are the Management Options for the Patient With AF and DES?

Which NOAC for Which Patient?

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Fundamental Knowledge: Left Atrium and Left Atrial Appendage Anatomy, Function, and Relational Pathology

LAA Closure: First in Man With the Fourth-Generation Watchman Device

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Patient Selection for the Watchman Device: The European Perspective

Watchman Patient Selection: US Perspective

Interventional Options for Left Atrial Appendage Exclusion

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Case Presentation: LAA Occlusion and TAVR

Safety of LAA Exclusion With the Lariat Device

Case Presentation 73 Year Old Man with Bacteremia and Left Atrial Mass

SESIÓN V: Cierre de la orejuela izquierda en fibrilación auricular

CIERRE DE LA OREJUELA DE AURICULA IZQUIERDA VS ANTICOAGULACION ORAL

LAA Occlusion for Stroke Prevention in A-Fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content